Old Web
English
Sign In
Acemap
>
authorDetail
>
David W. Scott
David W. Scott
Durham University
Epithelial sodium channel
Medicine
Pathology
Immunology
Peptide
8
Papers
64
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
SPX-101 is stable in and retains function after exposure to cystic fibrosis sputum
2019
Journal of Cystic Fibrosis
J. Sesma
Bryant Wu
Timothy J. Stuhlmiller
David W. Scott
Show All
Source
Cite
Save
Citations (9)
ENaC inhibitory peptides as regulators of fluid hydration on the eye
2018
Investigative Ophthalmology & Visual Science
David W. Scott
Show All
Source
Cite
Save
Citations (0)
WS18.6 SPX-101 is a novel peptide-based therapeutic targeting ENaC that restores mucus transport
2017
Journal of Cystic Fibrosis
David W. Scott
Matthew P. Walker
Timothy J. Stuhlmiller
W. Bryant
J. Sesma
Juan R. Sabater
William M. Abraham
Robert Tarran
Show All
Source
Cite
Save
Citations (0)
SPX-101 Is a Novel Epithelial Sodium Channel–targeted Therapeutic for Cystic Fibrosis That Restores Mucus Transport
2017
American Journal of Respiratory and Critical Care Medicine
David W. Scott
Matthew P. Walker
Juliana I. Sesma
Bryant Wu
Timothy J. Stuhlmiller
Juan R. Sabater
William M. Abraham
Timothy M. Crowder
Dale J. Christensen
Robert Tarran
Show All
Source
Cite
Save
Citations (38)
Redox-Regulation of α-Mannosidases: A Novel Target for Endothelial Cell Dysfunction
2016
Free Radical Biology and Medicine
Kellie M. Regal
David W. Scott
Rakesh P. Patel
Show All
Source
Cite
Save
Citations (0)
1